These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 5003899)
1. Recent advances in the pharmacology of tetrahydrocannabinols. Shideman FE Nihon Yakurigaku Zasshi; 1971 Sep; 46(5):113P-115P. PubMed ID: 5003899 [No Abstract] [Full Text] [Related]
2. General and behavioral pharmacology. Harris LS Pharmacol Rev; 1971 Dec; 23(4):285-94. PubMed ID: 4943947 [No Abstract] [Full Text] [Related]
3. Central nervous system actions of some synthetic tetrahydrocannabinol derivatives. Domino EF; Hardman HF; Seevers MH Pharmacol Rev; 1971 Dec; 23(4):317-36. PubMed ID: 5003209 [No Abstract] [Full Text] [Related]
4. The changes in vitamin B6 and brain amine metabolism in mice chronically treated with delta-9-tetrahydrocannabinol. Colombini CE; Westfall TC; McCoy EE Act Nerv Super (Praha); 1974 Mar; 16(1):68-9. PubMed ID: 4454949 [No Abstract] [Full Text] [Related]
5. Rapid depletion of adrenal epinephrine and elevation of telencephalic serotonin by (-)-trans- 9 -tetrahydrocannabinol in mice. Welch BL; Welch AS; Messiha FS; Berger HJ Res Commun Chem Pathol Pharmacol; 1971 May; 2(3):382-91. PubMed ID: 5149894 [No Abstract] [Full Text] [Related]
6. [Pharmacology of marihuana]. Carlini EA Arch Invest Med (Mex); 1974; 5 SUPPL 1():151-60. PubMed ID: 4614731 [No Abstract] [Full Text] [Related]
7. Pharmacological study of 2-ethyl-4-ethylamino-6-methoxy-s-triazine, a new compound with both central sympathetic and parasympathetic stimulating properties. Chiba S; Saji Y; Hibino H; Takeo Y; Yui T Arzneimittelforschung; 1968 Mar; 18(3):303-9. PubMed ID: 4386816 [No Abstract] [Full Text] [Related]
8. Cannabis: a psychopharmacological review. Bech P; Rafaelsen L; Rafaelsen OJ Dan Med Bull; 1974 May; 21(3):106-20. PubMed ID: 4209151 [No Abstract] [Full Text] [Related]
9. Evaluation of the hypothermic action of tetrahydrocannabinols in mice and squirrel monkeys. Haavik CO; Hardman HF J Pharmacol Exp Ther; 1973 Dec; 187(3):568-74. PubMed ID: 4203720 [No Abstract] [Full Text] [Related]
10. Structure-activity relationships in the tetrahydrocannabinol series. Modifications on the aromatic ring and it the side-chain. Edery H; Grunfeld Y; Porath G; Ben-Zvi Z; Shani A; Mechoulam R Arzneimittelforschung; 1972 Nov; 22(11):1995-2003. PubMed ID: 4633591 [No Abstract] [Full Text] [Related]
11. The effects of delta-9-tetrahydrocannabinol on the metabolism of norepinephrine in rat brain. Schildkraut JJ; Efron DH Psychopharmacologia; 1971; 20(2):191-6. PubMed ID: 5090538 [No Abstract] [Full Text] [Related]
12. Effects of delta9-tetrahydrocannabinol on the metabolism of 3H-5-hydroxytryptamine and 3H-norepinephrine in the rat brain. Ho BT; Taylor D; Englert LF Res Commun Chem Pathol Pharmacol; 1974 Apr; 7(4):645-50. PubMed ID: 4828760 [No Abstract] [Full Text] [Related]
13. Attack behaviour in mice inhibited by -9-tetrahydrocannabinol. Kilbey MM; Fritchie GE; McLendon DM; Johnson KM Nature; 1972 Aug; 238(5365):463-5. PubMed ID: 4561858 [No Abstract] [Full Text] [Related]
14. The effects of some drugs on an evoked response sensitive to tetrahydrocannabinols. Boyd ES; Boyd EH; Brown LE J Pharmacol Exp Ther; 1974 Jun; 189(3):748-58. PubMed ID: 4210510 [No Abstract] [Full Text] [Related]
15. Effect of 9 -tetrahydrocannabinol on a cholinergic-induced activation of the electroencephalogram in the rabbit. Consroe PF Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):705-12. PubMed ID: 4701266 [No Abstract] [Full Text] [Related]
16. Asymmetrical effect of delta-9-tetrahydrocannabinol (THC) on striatal dopamine and behavior. Waters DH; Glick SD Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):57-63. PubMed ID: 4734017 [No Abstract] [Full Text] [Related]